ASCO 2016 Melanoma Highlights: developments in immunotherapy, MEK inhibitors, and follow-up data on checkpoint inhibitors

James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the highlights in melanoma from the 2016 Annual Meeting of the American Society of Oncology (ASCO), held in Chic... Author: VJOncology Added: 08/26/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts